Dr. Oz Advocates for AI in Congress
Dr. Oz Champions AI in Congressional HearingIn a recent Senate Finance Committee confirmation hearing, Dr. Mehmet Oz, nominated by President Donald Trump to lead the Centers for Medicare and Medicaid, showcased his charisma and...
Eric Green Departure from National Human Genome Research Institute
Amidst the changing landscape of public health in America under the Trump administration, Eric Green, the longstanding director of the National Human Genome Research Institute (NHGRI), has made an unexpected departure from his role....
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee policy. Pitts, who served as the senior official in charge...
AI Risks for Disabled Individuals: Understanding Vulnerabilities
AI Risks for Disabled Individuals: Understanding VulnerabilitiesIn today's fast-paced world of advancing technology, artificial intelligence (AI) has become an integral part of healthcare. However, a recent report by the Center for Democracy and Technology...
Trump’s FDA and NIH Picks, FDA Office Crunch: Pharmalittle Update
As the week comes to a close, many of us are looking forward to some well-deserved rest and relaxation. Personally, I'm excited to spend time with loved ones, walk my furry friends, and enjoy...
Criticism from Industry Group on UK Drug Rebate Increase
U.K. Industry Group Criticizes Drug Rebate Increase ProposalA recent government proposal in the U.K. to raise mandatory rebates for drug companies aimed at supporting the National Health Service (NHS) has sparked intense criticism from...
NIH Prepares for Budget Cuts and Centralized Control
The National Institutes of Health are bracing for significant budget cuts and centralized control, sending ripples of fear and confusion through the scientific community. Scientists, administrators, and other employees are left uncertain about the...
RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised
Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
Senate Health Committee Approves Trump’s FDA and NIH Nominees
In a recent development, the Senate health committee has voted to approve Marty Makary as the Food and Drug Administration commissioner and Jay Bhattacharya as the director of the National Institutes of Health (NIH)....
Medical Device Safety Incident Reporting Study: FDA Late Reporting Frequency
A recent study published in the BMJ sheds light on the concerning frequency of late reporting of medical device safety incidents to the Food and Drug Administration (FDA). Manufacturers are required to report issues...
Study on Vaccines and Autism Impacting RFK Jr.’s Pledges
A recent development in the world of healthcare has sparked controversy and intrigue, as reports of a proposed federal study on the potential link between vaccines and autism have surfaced. This study, reportedly planned...
Devastating Toll: New Epidemic Surpasses Covid Deaths
The devastating impact of the overdose crisis has surpassed the death toll from Covid-19 in recent years. While the Covid-19 pandemic has captured global attention and resources, the ongoing drug crisis has quietly taken...
BREAKING NEWS
NYU School of Global Public Health Wins STAT Madness Vote
In a spirited celebration of scientific discovery, the recent STAT Breakthrough Summit East in Manhattan hosted a unique event that drew parallels to the...
